Lincolnshire, Ill.-based Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems, and flow cytometry testing technology for optimal clinical laboratory performance, has added the FDA-cleared XN-10 Automated Hematology Analyzer with Blood Bank mode to its portfolio of hematology solutions. This latest analyzer supports red blood cell (RBC) and platelet component testing and provides an automated complete blood count with differential (CBC/DIFF) for whole blood samples. Sysmex is the first and only original equipment manufacturer of automated hematology devices to receive FDA-cleared intended use claims for the blood center/blood bank market. The XN Blood Bank mode is intended for use in blood processing centers for QC release testing of post-processed components.
Blood component quality is key in transfusion medicine and blood product manufacturing. Sysmex America’s XN Blood Bank mode is a holistic solution that offers accurate cell counts on products that are key to blood centers and blood banks. With no sample preparation or pre-dilution required, the XN Blood Bank mode provides precise and rapid cell counts for greater confidence in blood product quality.
“Sysmex America’s XN-10 Automated Hematology Analyzer with Blood Bank mode is the next component in the widely used XN-Series,” says Andy Hay, chief operating officer of Sysmex America. “From donor qualification to product quality monitoring, blood centers will gain increased efficiency, consistency, and accuracy while providing life-saving blood products.”
Available as a single module (XN-1000BB) or twin co-primary analyzers (XN-2000BB), the scalable hematology analyzer may be installed as a tabletop analyzer or placed on wagons, and either model may be made even more efficient with the addition of the RU-20 reagent unit.
Featured image: Sysmex America’s XN Blood Bank mode offers accurate cell counts on products that are key to blood centers & blood banks. (Credit: Sysmex America)